Technical Analysis for FRLN - Freeline Therapeutics Holdings plc

Grade Last Price % Change Price Change
F 12.49 4.96% 0.59
FRLN closed down 2.3 percent on Thursday, April 22, 2021, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical FRLN trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 4.96%
NR7 Range Contraction 4.96%
Oversold Stochastic Weakness 4.96%
Doji - Bullish? Reversal 2.55%
Oversold Stochastic Weakness 2.55%
Stochastic Reached Oversold Weakness 2.04%
Oversold Stochastic Weakness 2.04%
NR7 Range Contraction 2.13%
Inside Day Range Contraction 0.56%
Inside Day Range Contraction 0.00%
Older End-of-Day Signals for FRLN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support 5 minutes ago
Gap Up Partially Closed 5 minutes ago
Rose Above 10 DMA 5 minutes ago
Gapped Up (Full) 14 minutes ago
Rose Above Previous Day's High 15 minutes ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Freeline is a clinical-stage biotechnology company focused on AAV-based gene therapy targeting the liver. Its vision is to create better lives for people suffering from chronic, systemic diseases using the potential of gene therapy as a one-time treatment to provide a potential functional cure. Freeline is headquartered in the U.K. and has operations in Germany and the U.S.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Gene Therapy Medical Genetics Applied Genetics Gene Delivery Gene Therapy Of The Human Retina

Is FRLN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.69
52 Week Low 11.8505
Average Volume 8,900
200-Day Moving Average 0.00
50-Day Moving Average 13.90
20-Day Moving Average 12.81
10-Day Moving Average 12.43
Average True Range 0.81
ADX 24.24
+DI 10.06
-DI 18.12
Chandelier Exit (Long, 3 ATRs ) 12.21
Chandelier Exit (Short, 3 ATRs ) 14.28
Upper Bollinger Band 13.99
Lower Bollinger Band 11.64
Percent B (%b) 0.11
BandWidth 18.36
MACD Line -0.54
MACD Signal Line -0.52
MACD Histogram -0.0257
Fundamentals Value
Market Cap 413.46 Million
Num Shares 34.7 Million
EPS
Price-to-Sales 0.00
Price-to-Book 4.68
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.53
Resistance 3 (R3) 12.59 12.45 12.43
Resistance 2 (R2) 12.45 12.29 12.42 12.39
Resistance 1 (R1) 12.17 12.19 12.10 12.11 12.35
Pivot Point 12.03 12.03 11.99 12.00 12.03
Support 1 (S1) 11.75 11.87 11.68 11.69 11.45
Support 2 (S2) 11.61 11.77 11.58 11.41
Support 3 (S3) 11.33 11.61 11.38
Support 4 (S4) 11.27